The acute effects of surfactant instillation rate on the cerebral and cardiovascular haemodynamics were studied in a randomised trial of 27 preterm neonates with respiratory distress syndrome (RDS 
There is abundant evidence that surfactant replacement therapy improves pulmonary function in preterm infants with respiratory distress syndrome (RDS). The effects of this treatment on intracerebral complications, such as periventricular cerebral haemorrhage or leucomalacia, are less certain.1 2 The administration of surfactant into the trachea has been associated with acute changes in cerebral blood flow velocity (CBFV) and electroencephalogram (EEG) abnormalities.3 Such changes, together with possible shunting through the ductus arteriosus, might increase the risk of cerebral lesions. We have already reported that 20 minutes after its administration Exosurf was not associated with any changes in CBFV and systemic haemodynamics. 4 In that study the synthetic surfactant was instilled using a perfusion pump over 30 minutes. In view of this we attempted to determine in a randomised study whether the instillation rate of (Exosurf) will induce acute changes in CBFV, EEG, and cardiovascular haemodynamics including mean arterial blood pressure (MABP), left ventricular output (LVO), and patency of the ductus arteriosus.
Methods
The study was conducted on 27 consecutive newborn infants who had been admitted to the neonatal intensive care unit of the University Hospital, Tours, France. All babies entering the study had severe RDS, as judged by an a/A partial oxygen pressure (Po2) ratio of less than 0-22. The criteria for diagnosing RDS were as follows: tachypnoea (more than 60 breaths/minute), substernal and intercostal recession; grunting and clinical diagnosis supported by radiological appearances. In all babies the lecithin:sphingomyelin (L:S) ratio in the tracheal aspirate was less than 1-5, mean (SD) 1-15 (0-31) . The infants were randomly assigned to receive as quickly as possible after birth a synthetic surfactant (Exosurf) either rapidly over a period of five minutes or slowly over a period of 15 minutes. All infants were receiving mechanical ventilation with a fractional inspired oxygen (Fio2) of 60% or more to maintain a transcutaneous carbon dioxide tension (TcPco2) between 5-3 and 6-6 kPa (40 and 50 mm Hg) and a transcutaneous oxygen tension (TcPo2) between 8 and 953 kPa (60 and 70 mm Hg).
Surfactant studies were begun when the infants were less than 12 hours old. After endotracheal suctioning surfactant was administered via the sideport on the special endotracheal tube adaptor without interrupting mechanical ventilation. During surfactant instillation, Fio2 was increased so that the arterial oxygen saturation (Sao2) (Datex; pulse oximeter) remained within clinically accepted limits (95-97%). The newborns were not hyperventilated. In the rapid instillation group a 5 mI/kg dose of surfactant was administered by bolus injection over five minutes. Surfactant was instilled in small bursts timed with inspiration, the infant's head being in the midline. In the slow instillation group the surfactant was given manually over 15 minutes, with the babies lying supine and the head in middle position. All infants received an additional dose 12 hours later. Only the effects ofthe first dose were studied. None of the infants was sedated nor were they paralysed. Consent for the investigation was obtained from the infants' parents before each study. The p values were not significant.
was measured continuously via an umbilical artery catheter using a Baxter pressure transducer and was recorded on a Roche-Kontron monitor. The P02 and Pco2 were measured transcutaneously (Supermon Kontron). Calibration was performed in vivo using arterial blood gas checks as reference values.
Doppler echocardiographic assessment of left ventricular output and ductus arteriosus were performed 10 minutes before treatment, and one, three, and six hours after the administration of surfactant. All subjects were studied with an ATL ultramark 4 scanner with range gated pulsed Doppler. Left ventricular output was calculated from the following formula:
LVO=mean velocity.vessel area.heart rate.6 A 5 mHz transducer was used for Doppler measurement. The Doppler sample volume was positioned at the sinotubular junction of the aorta by using a subcostal view. Angle correction was applied for the angle 0. Systolic mean velocity was measured by tracing the middle of the most dense portion of the Doppler spectra. For at least three beats the velocity area was computed. Heart rate was measured from the R-R interval. The aortic vessel diameter was determined by using a 7.5 mHz transducer. A parasternal long axis view was used and the internal diameter was measured at the sinotubular junction in systole using two-dimensional echocardiographic images. The average of three measurements was used to calculate the vessel area according to the formula:
The ductus was imaged from the high left parasternal position. The Doppler sample volume was placed in the pulmonary end of the duct and the flow pattern was recorded. The ductus was classified as patent when patency could be imaged and Doppler flow could be detected. Otherwise it was classified closed.
STATISTICAL ANALYSIS
Student's t test and x2 analysis were used to evaluate differences between variables of the two groups treated with different instillation rate of surfactant. For all repeated measurements, a two factor analysis of variance was carried out, the factors being time and instillation rate. Measurements were repeated on the first factor (time). The association of MABP, TcPco2, and CBFV were assessed by multiple linear regression analysis. Changes in TcPo2 were not considered an independent effect of surfactant because FiO2 was adjusted as part of the administration protocol. A p value of <0-05 was considered significant. Results A total of 27 patients were consecutively enrolled: 13 received a rapid instillation of surfactant and 14 received a slow instillation of between the two groups. All infants received a second dose 12 hours after the initial treatment.
Cerebral ultrasound scans were normal in the 27 infants before surfactant. During the seven days following the administration of surfactant, three of the 13 infants in the rapid group developed germinal layer haemorrhages and two developed periventricular leucomalacia. Four fig 3 that the slow rise in carbon dioxide over 10 minutes (even allowing for the response time of TcPco2 monitors) is not the whole explanation for the very rapid change (38%) in CBFV. We speculate that the airway obstruction caused by the large volume of surfactant could have decreased venous return to the heart and increased cerebral blood volume. CBFV may also be subject to variation in Po2. In the present study, however, FiO2 was immediately adjusted during and after administration in response to change value observed by the monitors.
MABP remained stable in the rapid as well as the slow instillation group. Using a natural porcine surfactant, several authors have noticed a significant decrease in MABP as soon as two minutes after surfactant administration.3 9 It is likely that a rapid decrease in pulmonary vascular resistance, as a result of lung expansion, could have promoted ductal shunting and therefore lowered blood pressure. 1 
